Ganymed Pharmaceuticals Ag

Johannes Gutenberg-universität Mainz

Astellas Pharma Gmbh

Ganymed Pharmaceuticals Gmbh

Tron—translationale Onkologie an Der Universitátsmedizin Der Johannes Gutenberg—universität Mainz Gemeinnützige Gmbh

Tron—translationale Onkologie an Der Universitat

Phillippe Thiel

Ugur Sahin

Dirk Usener

Harald-Gerhard Geppert

Stefan Fritz

Gunda Brandenburg

Anja Kristina Schröder

Christoph Uherek

Özlem Türeci

Ozlem Tureci

The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLD18, including tumor-related diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder.

Monoclonal antibodies against Claudin-18 for treatment of cancer

Monoclonal antibodies against claudin-18 for treatment of cancer

The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLD1 8, including tumor-related diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder.

Growing community of inventors

Planegg, Germany

Phillippe Thiel